Tema ETFs has announced the appointment of Prof. Jens Juul Holst, a renowned pioneer in GLP-1 research, to its Scientific Advisory Board. This strategic addition aims to bolster the ETF provider's expertise in the rapidly evolving GLP-1 drug market.
GLP-1 Pioneer Prof. Jens Juul Holst Appointed Tema ETFs Scientific Advisor
ETFsBiotechGLP-1PharmaceuticalsHealthcare

